Quince Therapeutics, Inc.
NASDAQQNCX short interest surges 28% in one week to 3.06% of float, driven by heavy short accumulation amid biotech selloff.
Snapshot as of 28 Jun 2026
No long-form analysis yet for QNCX. Pulse alerts and the live data picture are available on ORTEX.
Open QNCX on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for QNCX — free to start on ORTEX.
Sign up for free →Open QNCX on ORTEX